Researchers discover new genetic mutation that causes male infertility
Researchers at Ben-Gurion University of the Negev and Soroka University Medical Center in Beer-Sheva, Israel have discovered a new genetic mutation that prevents sperm production.
TBIT, pixabay.com, CC0
Five percent of men suffer from infertility and approximately one percent suffer from azoospermia, which is a condition in which sperm cells are completely absent.
For the first time, the researchers identified a mutation in the gene TDRD9 using whole genome genotyping and sequencing. The results were published in the Journal of Medical Genetics.
The findings were possible only because five men from a single Bedouin family suffered from lack of sperm and spermatogenic arrest in their testis with no obvious cause. The men were being treated by Dr. Eitan Lunenfeld and his team at the Soroka University Medical Center In Vitro Fertilization Unit.
Profs. Ruti Parvari and Mahmoud Huleihel of the Shraga Segal Department of Microbiology, Immunology and Genetics discovered the mutation in the gene, which normally protects the full DNA sequence in sperm. This mutation inactivates the function of the gene and arrests sperm production.
"With the link between this damaged gene and male infertility now identified, specific scans will be available to test for the mutation which will be important for treatment of a couple's infertility," the researchers say.
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
PolyTherics receives a Technology Strategy Board grant to develop novel fusion proteins
Research shows Vitamin D levels drop after pediatric heart surgery
Centauri Therapeutics closes £24 million GBP Series A investment round - Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates
'Squirtable' elastic surgical glue seals wounds in 60 seconds
U-M creates state’s first disease-specific human embryonic stem cell lines
ORVACS Phase II clinical study attacks the viral reservoir of HIV patients
Ambion to Provide MitoCheck Consortium a Genome-Wide siRNA Library
A pentavalent inhibitor for cholera toxin
QIAGEN joins CANCER-ID consortium for liquid biopsy workflows - Public-private partnership aims to standardize and clinically validate blood-based biomarkers
Promosome LLC and Recopharma AB Announce Technology Partnership
